Genetic Etiology in Premature Ovarian Insufficiency (POI)
Sponsor: BEGUM AYDOGAN
Listed as NCT01973075, this observational or N/A phase trial focuses on Genetic Predisposition to Disease and Primary Ovarian Insufficiency and remains completed. Sponsored by BEGUM AYDOGAN, it has been updated 12 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Completed NA
-
Aug 2017 — Feb 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BEGUM AYDOGAN
- Istanbul University
For direct contact, visit the study record on ClinicalTrials.gov .